• -11%
Superdrol Inj (Methyldrostanolone) Injectable | Dragon Pharma
search
  • Superdrol Inj (Methyldrostanolone) Injectable | Dragon Pharma

Superdrol Inj

$75.00
$66.75 Save 11%

Methyldrostanolone

Superdrol Injβ€’40 mg/ml
Class Injectable 17Ξ±-Methyl AAS
Concentration 40 mg/ml
Anabolic Ratio 400
Androgenic Ratio 20
Carrier MCT Oil
Form Injection, 10ml
Quantity

  Security policy

(edit with the Customer Reassurance module)

  Delivery policy

(edit with the Customer Reassurance module)

  Return policy

(edit with the Customer Reassurance module)

Superdrol Injectable β€” Methyldrostanolone 40mg/ml by Dragon Pharma

Superdrol Injectable is Dragon Pharma's injectable formulation of Methyldrostanolone at 40mg/ml in MCT oil β€” the same active compound as Superdrol 10mg tablets, administered via intramuscular injection to bypass the first-pass hepatic metabolism that drives oral Superdrol's severe hepatotoxicity. For the complete compound background β€” including the methylated Masteron structure, prohormone history and mechanism β€” see the oral Superdrol page.

Also searched as: Injectable Superdrol, Methyldrostanolone injection, Superdrol Inj Dragon Pharma, injectable methasterone.

Why Injectable β€” The Hepatotoxicity Reduction Rationale

Injectable Methyldrostanolone is unusual β€” 17-alpha-alkylated compounds are almost exclusively oral because the alkylation's primary purpose is oral bioavailability. The injectable format addresses the oral form's core limitation:

  • When oral Superdrol is swallowed, 100% of the absorbed dose passes through the liver (first-pass metabolism) before reaching systemic circulation. The 17-alpha-methyl group protects the compound from hepatic breakdown β€” but this resistance also means the compound is fully present in liver tissue at high concentration during this first pass, driving the severe hepatotoxicity
  • When Superdrol is injected intramuscularly, it enters the bloodstream directly β€” bypassing the first-pass hepatic exposure entirely. The compound still reaches the liver via systemic circulation, but at the systemic blood concentration rather than the concentrated first-pass dose
  • The result: injectable Methyldrostanolone produces significantly lower liver enzyme elevation than the oral form at equivalent doses β€” though hepatotoxicity is not eliminated (the compound still passes through the liver systemically) β€” it is meaningfully reduced
  • This reduction in first-pass hepatic load is the primary reason for the injectable format's existence β€” it allows Superdrol's anabolic effects to be used with a more manageable hepatic safety profile

Oral vs Injectable Superdrol β€” The Practical Comparison

Parameter Superdrol Injectable (40mg/ml) Superdrol Oral (10mg/tab)
Route Intramuscular injection Oral tablet
First-pass hepatic exposure Bypassed β€” systemic delivery only 100% first-pass through liver
Hepatotoxicity Reduced β€” still present systemically Severe β€” first-pass concentration
Bioavailability Near-complete via IM Moderate β€” first-pass metabolism
Convenience Injection required Oral tablet β€” most convenient
Dose precision Volume-based β€” flexible Tablet-based β€” 10mg increments
Same anabolic compound Yes β€” identical active molecule Yes

Dosage and Administration

Protocol Dose Frequency Duration
Standard performance 20–40 mg/day Daily IM injection 4–6 weeks maximum
Conservative start 20 mg/day (0.5ml) Daily Assess hepatic response before escalating

At 40mg/ml, a 0.5ml daily injection delivers 20mg; a 1ml injection delivers 40mg. The IM injection route is typically gluteal, vastus lateralis or deltoid β€” rotating sites daily. Because hepatotoxicity is reduced but not eliminated, cycle length is still strictly limited to 4-6 weeks, which is somewhat longer than the 3-4 week oral cycle maximum due to the reduced first-pass load. Liver enzyme monitoring remains essential throughout.

Comments (0)
No customer reviews for the moment.